Baylor College of Medicine: Genome Sequencing Identifies Cancer's Achilles Heel in Exceptional Responders
November 20, 2020
November 20, 2020
HOUSTON, Texas, Nov. 20 (TNSJou) -- The Baylor College of Medicine issued the following news release:
Some advanced-cancer patients defy the odds and the prognosis, living much longer than other patients with clinically comparable tumors. What can we learn from this group, referred to as exceptional responders? Researchers at Baylor College of Medicine led a six-year study with the National Cancer Institute to analyze the tumor genome and microenvironment of exceptional responders t . . .
Some advanced-cancer patients defy the odds and the prognosis, living much longer than other patients with clinically comparable tumors. What can we learn from this group, referred to as exceptional responders? Researchers at Baylor College of Medicine led a six-year study with the National Cancer Institute to analyze the tumor genome and microenvironment of exceptional responders t . . .